Original Research
Copyright ©The Author(s) 1997. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 15, 1997; 3(4): 218-220
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.218
Effects of somatostatin analog on splanchnic hemodynamics and plasma glucagon level in portal hypertensive rats
Zhi-Yong Wu, Xiao-Jie Zhao, Zhe Jiao, Zhi-Ping Chen, Yao-Ling Kuang
Zhi-Yong Wu, Xiao-Jie Zhao, Zhe Jiao, Zhi-Ping Chen, Yao-Ling Kuang, Department of Surgery, Renji Hospital Shanghai Second Medical University, Shanghai 200001, China
Zhi-Yong Wu, MD, a Postdoctoral Fellow in Louisiana State University Medical Center, Shreveport, USA between July 1, 1991 and June 30, 1994, now Professor and Vice Director of the Department of Surgery, having more than 40 papers published.
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China (No. C38970703).
Correspondence to: Zhi-Yong Wu, MD, Department of Surgery, Renji Hospital Shanghai Second Medical University, Shanghai 200001, China
Received: April 27, 1997
Revised: May 22, 1997
Accepted: June 14, 1997
Published online: December 15, 1997
Abstract

AIM: To investigate the effects of somatostatin analog on splanchnic hemodynamics and plasma glucagon level in portal hypertensive rats.

METHODS: Twenty-eight male Sprague-Dawley rats were equally divided into a intrahepatic portal hypertension (IHPH) model group (n = 14, established by injection of CCl4) and a prehepatic portal hypertension (PHPH) model group (n = 14, established by stenosis of the portal vein). Animals in each group were subdivided into an octreotide treatment (injection) group and a control (normal saline injection) group. Seven age-matched unmodeled/untreated normal rats served as controls. The mean systemic arterial pressure (MSAP) and free portal venous pressure (FPP) were measured. The splanchnic blood flow was detected by injection of toad blood red cell labelled with 51Cr and 125I·T3. The concentration of plasma glucagon was determined by radioimmunoassay.

RESULTS: All rats with portal hypertension showed significantly decreased splanchnic blood flow and FPP in response to octreotide treatment, as well as markedly increased splanchnic vascular and portal venous resistance. The octreotide treatment did not appear to significantly lower the plasma glucagon levels in either the peripheral or the portal veins.

CONCLUSION: Octreotide induces a decrease in splanchnic blood flow in rats with portal hypertension, and this effect results primarily from direct vasoconstriction and to a lesser extent from decreased plasma glucagon level.

Keywords: Portal hypertension; Octreotide; Glucagon; Splanchnic hemodynamics; Somatostatin analog